DOI: http://dx.doi.org/10.18203/2320-6012.ijrms20175475

Isolated pulmonary cavitary mucormycosis in uncontrolled diabetic, diagnosed by fiber-optic bronchoscopy and completely managed medically

MD. Abdul Waseem, Misba Zahera, Gopalakrishnaiah V.

Abstract


Pulmonary mucormycosis is rare life‐threatening infection affecting mostly immunocompromised individuals such as diabetes mellitus, hematological malignancies, chronic renal failure, post transplantation etc. Based on the anatomic site involved, mucormycosis can be one of several forms, such as rhinocerebral, pulmonary, cutaneous, gastrointestinal, disseminated, and uncommon presentations that include endocarditis, osteomyelitis, peritonitis, and renal infection. Pulmonary infection is the most common form of mucormycosis recognized in patients with hematological malignancy and remains the second most common presentation after rhinocerebral infection in diabetic patients. Its presentation in the lungs may mimic cavitary diseases like tuberculosis, mass lesions as in malignancies and non-resolving pneumonias. Here we report a case of isolated pulmonary mucormycosis in an uncontrolled diabetic male patient with a cavitary lesion. Diagnosis was made with a bronchoscopic biopsy and treatment was completely medical with liposomal amphotericin B.


Keywords


Amphotericin B, Bronchoscopy, Mucormycosis, Non-resolving pneumonia, Pulmonary

Full Text:

PDF

References


Furbinger P. Observations on lungenmycose beinmeschen. Arch Pathol Anat Physiol Klin Med. 1876;66:330-65.

Petrikkos G, Skiada A, Lortholary O, Roilides E, Walsh TJ, Kon- toyiannis DP. Epidemiology and clinical manifestations of mucor-mycosis. Clin Infect Dis. 2012;54(Suppl 1):S23-S34.

McAdams HP, Rosado de Christenson M, Strollo DC, Patz Jr EF. Pulmonary mucormycosis: radiologic findings in 32 cases. AJR. Ame J Roentgenol. 1997;168(6):1541-8.

Roden MM, Zaoutis TE, Buchanan WL, Knudson TA, Sarkisova TA, Schaufele RL et al. Epidemiology and outcome of zygomycosis: a review of 929 reported cases. Clin Infect Dis. 2005;41(5):634-653.

Di Carlo P, Cabibi D, La Rocca AM, De Luca D, La Licata F, Sacco E. Post-bronchoscopy fatal endobronchial hemorrhage in a woman with bronchopulmonary mucormycosis: a case report. J Med Case Rep. 2010;4:398.

Chayakulkeeree M, Ghannoum MA, Perfect JR. Zygomycosis: The re-emerging fungal infection. Eur J Clin Microbiol Infect Dis. 2006;25:215-29.

Chinn RY, Diamond RD: Generation of chemotactic factors by Rhizopus oryzae in the presence and absence of serum: relationship to hyphal damage mediated by human neutrophils and effects of hyperglycemia and ketoacidosis. Infect Immun. 1982;38(3):1123-9.

Spellberg B, Edwards J Jr, Ibrahim A. Novel perspectives on mucormycosis: pathophysiology, presentation, and management. Clin Microbiol Rev. 2005;18(3):556-69.

Liu M, Spellberg B, Phan QT, Yue Fu, Yong Fu, Amy S. Lee et al. The endothelial cell receptor GRP78 is required for mucormycosis pathogenesis in diabetic mice. J Clin Invest. 2010;120(6):1914-192.

Lee FY, Mossad SB, Adal KA. Pulmonary mucormycosis: The last 30 years. Arch Intern Med. 1999;159:1301-9.

Georgiadou SP, Sipsas NV, Marom EM, Kontoyiannis DP. The diagnostic value of halo and reversed halo signs for invasive mold infections in compromised hosts. Clin Infect Dis. 2011;52(9):1144-55.

Kwon-Chung KJ, Bennett JE. Medical mycology. Revista do Instituto de Medicina Tropical de São Paulo. 1992;34(6):504.

Walsh TJ, Gamaletsou MN, McGinnis MR, Hayden RT, Kontoyyiannis DP et al. Early clinical and laboratory diagnosis of invasive pulmonary, extrapulmonary, and disseminated mucormycosis (zygomycosis). Clin Infect Dis. 2012;54(Suppl 1):S55-S60.

Tedder M, Spratt JA, Anstadt MP, Hegde SS, Tedder SD, Lowe JE: Pulmonary mucormycosis: results of medical and surgical therapy. Ann Thorac Surg. 1994;57(4):1044-50.

Petrikkos G, Skiada A, Sambatakou H, A. Toskas, G. Vaiopoulos, M. Gionnopoulou et al. Mucormycosis: ten-year experience at a tertiary-care center in Greece. Eur J Clin Microbiol Infect Dis. 2003;22(12):753-6.

Spellberg B, Ibrahim A, Roilides E, Lewis RE, Lortholary O, Petrikkos G, et al. Combination therapy for mucormycosis: why, what, and how?. Clini Infect Dis. 2012;54(suppl_1):S73-8.